University of New South Wales
myUNSW

:: Class Utilisation Summary 2016


Subject Area Index

See LEGEND for key to shading and symbols.


:: Subject Area - MFAC  Term - Semester 2

MFAC1511 (M2B) MFAC1512 (M2B) MFAC1513 (M2B) MFAC1517 (M2B) MFAC1519 (M2A) MFAC1523 (M2A)
MFAC1526 (M2B) MFAC1601 (M2A) MFAC2505 (M2A) MFAC2506 (M2A) MFAC2507 (M2B) MFAC2509 (M2A)
MFAC2511 (M2B) MFAC2512 (M2B) MFAC3501 (M2A) MFAC3501 (M2B) MFAC3502 (M2A) MFAC3503 (M2A)
MFAC3503 (M2B) MFAC3504 (M2A) MFAC3504 (M2B) MFAC3505 (M2A) MFAC3505 (M2B) MFAC3506 (M2A)
MFAC3506 (M2B) MFAC3508 (M2A) MFAC3508 (M2B) MFAC3509 (M2A) MFAC3509 (M2B) MFAC3512 (M2B)
MFAC3515 (M2B) MFAC3522 (M2B) MFAC3523 (M2B) MFAC4508 MFAC4509 MFAC4510

Data is correct as at Tue Oct 11 19:05:29 AEDT 2016


Comp Sect Class Type Status Enr/Cap % Full Times (weeks, Location) - default 1hour 
MFAC1511   Phase 1 Portfolio Examination (M2B)
OTHKEN 9706EnrOpen273/300 91%  
MFAC1512   Phase 1 End-of-Phase Exam (M2B)
OTHKEN 9707EnrOpen272/300 91%  
MFAC1513   Phase 1 Clin&Comm Skills Exam (M2B)
OTHKEN 9708EnrOpen273/300 91%  
MFAC1517   AE(Spec Prog) (M2B)
OTHKEN10337EnrOpen1/2 50%  
MFAC1519   HM (Spec Prog) (M2A)
OTHKEN10336EnrOpen1/2 50%  
MFAC1523   Health Maintenance A (M2A)
OTHKEN 9703EnrOpen539/600 90%  
MFAC1526   Ageing & Endings B (M2B)
OTHKEN 9705EnrOpen535/600 89%  
MFAC1601   Intro Clinical and Com Skills (M2A)
LECKEN 9709EnrFull13/13 100%  
MFAC2505   Integrated Clinical Studies A (M2A)
OTHCOFF 9714EnrOpen11/15 73%  
OTHKEN 9712EnrOpen115/180 64%  
OTHPORT 9715EnrOpen12/15 80%  
MFAC2506   Integrated Clinical Studies B (M2A)
OTHALBY 9716EnrOpen12/15 80%  
OTHGRIF 9718EnrOpen5/10 50%  
OTHKEN 9713EnrOpen119/180 66%  
OTHWAGA 9717EnrOpen12/15 80%  
MFAC2507   Clinical Transition (M2B)
OTHALBY 9723EnrOpen3/5 60%  
OTHCOFF 9724EnrOpen4/5 80%  
OTHKEN 9721EnrOpen219/235 93%  
OTHPORT 9725EnrOpen1/5 20%  
OTHWAGA 9726EnrOpen3/5 60%  
MFAC2509   Clinical Skills Refresher (M2A)
CLNKEN 9930EnrOpen3/5 60%  
MFAC2511   Phase 2 Portfolio Examination (M2B)
OTHKEN 9719EnrOpen18/25 72%  
MFAC2512   Phase 2 Integ Clin Assessment (M2B)
OTHKEN 9720EnrOpen282/300 94%  
MFAC3501   Medicine (M2A)
CLNALB3 9285EnrOpen1/20 5%  
MFAC3501   Medicine (M2B)
CLNALB4 9290EnrCanc0/30 0%  
MFAC3501   Medicine (M2A)
CLNCOF3 9286EnrOpen1/30 3%  
MFAC3501   Medicine (M2B)
CLNCOF4 9291EnrCanc0/30 0%  
MFAC3501   Medicine (M2A)
CLNKEN3 9284EnrOpen48/80 60%  
MFAC3501   Medicine (M2B)
CLNKEN4 9289EnrCanc0/80 0%  
MFAC3501   Medicine (M2A)
CLNPMC3 9287EnrOpen0/30 0%  
MFAC3501   Medicine (M2B)
CLNPMC4 9292EnrCanc0/30 0%  
MFAC3501   Medicine (M2A)
CLNWAG3 9288EnrOpen0/30 0%  
MFAC3501   Medicine (M2B)
CLNWAG4 9293EnrCanc0/30 0%  
MFAC3502   Surgery (M2A)
CLNALB3 9295EnrOpen1/30 3%  
CLNCOF3 9296EnrOpen1/30 3%  
CLNKEN3 9294EnrOpen49/80 61%  
CLNPMC3 9297EnrOpen0/30 0%  
CLNWAG3 9298EnrOpen0/30 0%  
MFAC3503   Psychiatry (M2A)
CLNALB3 9300EnrOpen6/30 20%  
MFAC3503   Psychiatry (M2B)
CLNALB4 9305EnrOpen4/30 13%  
MFAC3503   Psychiatry (M2A)
CLNCOF3 9301EnrOpen4/30 13%  
MFAC3503   Psychiatry (M2B)
CLNCOF4 9306EnrOpen4/30 13%  
MFAC3503   Psychiatry (M2A)
CLNKEN3 9299EnrOpen47/80 59%  
MFAC3503   Psychiatry (M2B)
CLNKEN4 9304EnrOpen27/80 34%  
MFAC3503   Psychiatry (M2A)
CLNPMC3 9302EnrOpen4/30 13%  
MFAC3503   Psychiatry (M2B)
CLNPMC4 9307EnrOpen3/30 10%  
MFAC3503   Psychiatry (M2A)
CLNWAG3 9303EnrOpen4/30 13%  
MFAC3503   Psychiatry (M2B)
CLNWAG4 9308EnrOpen3/30 10%  
MFAC3504   Primary Care (M2A)
CLNALB3 9310EnrOpen4/30 13%  
MFAC3504   Primary Care (M2B)
CLNALB4 9315EnrOpen5/30 17%  
MFAC3504   Primary Care (M2A)
CLNCOF3 9311EnrOpen3/30 10%  
MFAC3504   Primary Care (M2B)
CLNCOF4 9316EnrOpen3/30 10%  
MFAC3504   Primary Care (M2A)
CLNKEN3 9309EnrOpen47/80 59%  
MFAC3504   Primary Care (M2B)
CLNKEN4 9314EnrOpen26/80 33%  
MFAC3504   Primary Care (M2A)
CLNPMC3 9312EnrOpen4/30 13%  
MFAC3504   Primary Care (M2B)
CLNPMC4 9317EnrOpen4/30 13%  
MFAC3504   Primary Care (M2A)
CLNWAG3 9313EnrOpen3/30 10%  
MFAC3504   Primary Care (M2B)
CLNWAG4 9318EnrOpen3/30 10%  
MFAC3505   Obstetrics & Gynaecology (M2A)
CLNALB3 9320EnrOpen6/30 20%  
MFAC3505   Obstetrics & Gynaecology (M2B)
CLNALB4 9325EnrOpen6/30 20%  
MFAC3505   Obstetrics & Gynaecology (M2A)
CLNCOF3 9321EnrOpen5/30 17%  
MFAC3505   Obstetrics & Gynaecology (M2B)
CLNCOF4 9326EnrOpen4/30 13%  
MFAC3505   Obstetrics & Gynaecology (M2A)
CLNKEN3 9319EnrOpen26/80 33%  
MFAC3505   Obstetrics & Gynaecology (M2B)
CLNKEN4 9324EnrOpen48/80 60%  
MFAC3505   Obstetrics & Gynaecology (M2A)
CLNPMC3 9322EnrOpen4/30 13%  
MFAC3505   Obstetrics & Gynaecology (M2B)
CLNPMC4 9327EnrOpen3/30 10%  
MFAC3505   Obstetrics & Gynaecology (M2A)
CLNWAG3 9323EnrOpen4/30 13%  
MFAC3505   Obstetrics & Gynaecology (M2B)
CLNWGA4 9328EnrOpen5/30 17%  
MFAC3506   Children's Health (Paeds) (M2A)
CLNALB3 9330EnrOpen5/30 17%  
MFAC3506   Children's Health (Paeds) (M2B)
CLNALB4 9339EnrOpen6/30 20%  
MFAC3506   Children's Health (Paeds) (M2A)
CLNCOF3 9331EnrOpen4/30 13%  
MFAC3506   Children's Health (Paeds) (M2B)
CLNCOF4 9340EnrOpen5/30 17%  
MFAC3506   Children's Health (Paeds) (M2A)
CLNKEN3 9329EnrOpen31/80 39%  
MFAC3506   Children's Health (Paeds) (M2B)
CLNKEN4 9338EnrOpen42/80 53%  
MFAC3506   Children's Health (Paeds) (M2A)
CLNPMC3 9332EnrOpen4/30 13%  
MFAC3506   Children's Health (Paeds) (M2B)
CLNPMC4 9341EnrOpen4/30 13%  
MFAC3506   Children's Health (Paeds) (M2A)
CLNWAG3 9333EnrOpen4/30 13%  
MFAC3506   Children's Health (Paeds) (M2B)
CLNWAG4 9342EnrOpen4/30 13%  
MFAC3508   Emergency/Selective (M2A)
CLNALB3 9344EnrOpen1/30 3%  
MFAC3508   Emergency/Selective (M2B)
CLNALB4 9349EnrOpen1/30 3%  
MFAC3508   Emergency/Selective (M2A)
CLNCOF3 9345EnrOpen0/30 0%  
MFAC3508   Emergency/Selective (M2B)
CLNCOF4 9350EnrOpen1/30 3%  
MFAC3508   Emergency/Selective (M2A)
CLNKEN3 9343EnrOpen51/80 64%  
MFAC3508   Emergency/Selective (M2B)
CLNKEN4 9348EnrOpen51/80 64%  
MFAC3508   Emergency/Selective (M2A)
CLNPMC3 9346EnrOpen0/30 0%  
MFAC3508   Emergency/Selective (M2B)
CLNPMC4 9351EnrOpen0/30 0%  
MFAC3508   Emergency/Selective (M2A)
CLNWAG3 9347EnrOpen1/30 3%  
MFAC3508   Emergency/Selective (M2B)
CLNWAG4 9352EnrOpen0/30 0%  
MFAC3509   Selective (M2A)
CLNALB3 9354EnrOpen17/30 57%  
MFAC3509   Selective (M2B)
CLNALB4 9363EnrOpen0/30 0%  
MFAC3509   Selective (M2A)
CLNCOF3 9359EnrOpen16/30 53%  
MFAC3509   Selective (M2B)
CLNCOF4 9364EnrOpen0/30 0%  
MFAC3509   Selective (M2A)
CLNKEN3 9353EnrOpen84/200 42%  
MFAC3509   Selective (M2B)
CLNKEN4 9362EnrOpen0/80 0%  
MFAC3509   Selective (M2A)
CLNPMC3 9360EnrOpen19/30 63%  
MFAC3509   Selective (M2B)
CLNPMC4 9365EnrOpen0/30 0%  
MFAC3509   Selective (M2A)
CLNWAG3 9361EnrOpen12/30 40%  
MFAC3509   Selective (M2B)
CLNWAG4 9366EnrOpen0/30 0%  
MFAC3512   Phase 3 Biomed Sci Viva (M2B)
OTHBIOM 9367EnrOpen259/280 93%  
MFAC3515   PRINT (M2B)
CLNALB4 9369EnrOpen15/30 50%  
CLNCOF4 9370EnrOpen16/30 53%  
CLNKEN4 9368EnrOpen193/250 77%  
CLNPMC4 9371EnrOpen20/30 67%  
CLNWAG4 9372EnrOpen14/30 47%  
MFAC3522   Phase 3 Portfolio Examination (M2B)
OTH3PFL 9374EnrOpen263/280 94%  
MFAC3523   Phase 3 Integrated Clinical Ex (M2B)
OTH3ICE 9375EnrOpen264/280 94%  
MFAC4508   Independent Learning Project 1
OTHKEN10424EnrOpen2/30 7%  
MFAC4509   Independent Learning Project 2
OTHALBY 9780EnrOpen3/5 60%  
OTHCOFF 9781EnrOpen3/5 60%  
OTHKENS 9779EnrOpen216/235 92%  
OTHPORT 9782EnrOpen3/5 60%  
OTHWGGA 9783EnrOpen2/5 40%  
MFAC4510   ILP 1A
OTHKEN10420EnrOpen0/2 0%  
^ top ^
LEGEND
* This class requires consent. Students cannot self-enrol.
# Timetable clash allowed.
/odd  Runs in odd weeks only.     /even  Runs in even weeks only.
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity.
      Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes.
[  ] Class capacity where different from effective capacity.
  
Shaded cells:  LEC Activity different from previous
Stop Status is Stop Further Enrolment, Tentative, Closed or Cancelled
100%   Class is full (> 100% means capacity is exceeded)
80%   Class is nearly full (80% or more)
50%   Class is half full
0%   Class is less than half full